Tiziana Life Sciences is trading 6.73% up now at $1.11, with no clear catalyst identified.
- No company-specific announcement or filing dated August 14, 2026, explains the move.
- The latest investor-relations updates were insider-share purchases announced August 4 and August 6, not new today.
- Broader markets are only modestly higher, so the evidence does not establish a macro catalyst or direct cause.